Vinay Chaudhry

Vinay Chaudhry, a sole proprietorship based in Cockeysville, Maryland, provides medical expert services and case review consulting to federal agencies exclusively as a prime contractor under small-business set-asides, with 339 recent awards carrying $21.3 million in combined potential value. Chaudhry operates under NAICS 621111 (Offices of Physicians except Mental Health Specialists) and PSC code Support-Professional (Expert Witness), delivering specialized medical analysis and expert testimony for vaccine injury compensation litigation and federal health program adjudication.

Customer concentration is extreme: 315 of 339 awards (93% of total awards, 99.5% of combined potential value) flow from the Department of Health and Human Services Health Resources and Services Administration (HRSA) Headquarters, with the remaining six awards from the Department of Justice Civil Division. All work supports HRSA's Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP), where Chaudhry provides detailed medical case reviews, expert analyses, hearing preparation, and participation in vaccine injury compensation proceedings for individual claimant evaluations. The Department of Justice work involves similar medical expert services in support of tort litigation. Chaudhry has held continuous contracting relationships with HRSA since at least 2004, representing two decades of specialized focus on this single mission area.

Chaudhry operates under five active BPAs with HRSA, with the most recent single-award BPA established May 15, 2026, carrying a $7.5 million ceiling through May 14, 2030. The prior BPA, valued at $249,999 and awarded April 8, 2021, generated the bulk of activity over the past five years. The two largest vehicles by task-order count are Blanket Purchase Agreement HHSH250201400010B (144 task orders, $402 thousand combined value) and BPA 75R60219A00041 (81 task orders, $258 thousand combined value). Individual call orders range from $375 to $24,375, with case complexity and scope driving variation. Recent representative awards include a $24,375 medical case review BPA call for VICP (January 28, 2026), an $11,250 call for VICP and CICP expert services (March 20, 2026), and a $9,375 medical case review call (August 28, 2025).

Activity has been volatile — 32 awards in 2021 fell to five in 2022, then two in 2024 and three in 2025 — reflecting fluctuations in HRSA's case workload and procurement timing rather than loss of customer standing. The new $7.5 million BPA established in May 2026 signals continued reliance. Only three awards face completion within the next twenty-four months with combined potential value of $45 thousand, indicating minimal near-term recompete pressure. Chaudhry subcontracts to no other federal primes and receives no subcontract work; 100% of the footprint represents direct prime performance to HRSA on firm fixed-price BPA calls. All work is performed in Cockeysville, Maryland.